Нүүр зураг

Mexico Pharmaceuticals Report - November 2025

-д хадгалсан:
-д хэвлэсэн:Fitch Solutions Country Industry Reports (Nov 7, 2025), p. 1-56
Хэвлэсэн:
Fitch Solutions Group Limited
Нөхцлүүд:
Mexico
Pharmaceuticals
Statistical data
Industrywide conditions
Market analysis
Industry analysis
Business forecasts
SWOT analysis
Pharmaceutical industry
Онлайн хандалт:Citation/Abstract
Full Text - PDF
Шошгууд: Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

MARC

LEADER 00000nab a2200000uu 4500
001 3269572713
003 UK-CbPIL
022 |a 2976-4750 
035 |a 3269572713 
045 0 |b d20251107 
245 1 |a Mexico Pharmaceuticals Report - November 2025 
260 |b Fitch Solutions Group Limited  |c Nov 7, 2025 
513 |a Industry Report 
520 3 |a Mexico’s pharma sector is poised to expand despite persistent hurdles around procurement and patent protection. Demand for cutting-edge therapies targeting chronic conditions is climbing, and as Latin America’s second-largest market, Mexico offers sizable openings for firms developing innovative medicines. That said, relatively low per-capita drug spending could limit widespread adoption of branded, patented products, likely boosting the role of generics. At the same time, government initiatives to bolster domestic manufacturing are expected to spur more cross-border partnerships, with a particular focus on technology transfer. 
651 4 |a Mexico 
653 |a Pharmaceuticals 
653 |a Statistical data 
653 |a Industrywide conditions 
653 |a Market analysis 
653 |a Industry analysis 
653 |a Business forecasts 
653 |a SWOT analysis 
653 |a Pharmaceutical industry 
773 0 |t Fitch Solutions Country Industry Reports  |g (Nov 7, 2025), p. 1-56 
786 0 |d ProQuest  |t ABI/INFORM Trade & Industry 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3269572713/abstract/embedded/6A8EOT78XXH2IG52?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3269572713/fulltextPDF/embedded/6A8EOT78XXH2IG52?source=fedsrch